News
News
- Chi-Med Plans to Submit Marketing Authorization Application for Surufatinib Following Scientific Advice from EMA’s CHMP
08:00 - GlobeNewswire - Addex Therapeutics to Release Half-Year 2020 Financial Results and Host Conference Call on August 12, 2020
07:00 - GlobeNewswire - WISeKey Completes $5 Million Private Placement with Crede Capital Group
07:00 - GlobeNewswire - Par Pacific Holdings Reports Second Quarter 2020 Results
00:00 - GlobeNewswire - OpGen Co-Markets COVID-19 Antibody Test Kit
08/09/2020 / 22:15 - GlobeNewswire - Amazon to buy mall places to speed up delivery - report
08/09/2020 / 22:01 - TeleTrader - Lebanon's future is at stake - Macron
08/09/2020 / 14:26 - TeleTrader - CSE Bulletin: Fundamental Change - Winston Resources Inc./Vegaste Technologies Corp.
08/07/2020 / 20:58 - Newsfile Corp - Amarin Supports Investigator-Initiated Trial at Kaiser Permanente in the U.S. to Study the Effects of VASCEPA® (icosapent ethyl) in Reducing Viral Upper Respiratory Infections, Including COVID-19 and Flu, and the Clinical Severity of Such Infections
08/07/2020 / 18:12 - GlobeNewswire - McEwen Mining Reports Q2 2020 Results
08/07/2020 / 01:28 - GlobeNewswire
Real-time